Twist Bioscience Corporation
A maker of synthetic DNA, Twist Bioscience writes custom genes and gene fragments on tiny silicon chips, shrinking the synthesis process dramatically. Its tools help researchers and drug developers discover and optimize antibodies, while its NGS products—target enrichment probes, library prep kits, and synthetic controls—are used in diagnostic tests for cancer, rare disease, and infectious disease. The company serves over 3,800 customers worldwide.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| ARK Investment Management LLC | 13G/APassive | 7.31% | 4.55M | Aug 14, 2026 |
| Catherine D. Wood | 13G/APassive | 7.31% | 4.55M | Aug 14, 2026 |
| T. Rowe Price Associates, Inc. | 13GPassive | 5.8% | 3.63M | Aug 14, 2026 |
| EdgePoint Investment Group Inc. | 13G/APassive | 4.21% | 2.52M | Aug 14, 2026 |
| Artisan Partners Asset Management Inc. | 13G/APassive | 7.7% | 4.80M | Aug 13, 2026 |
| Artisan Partners Holdings LP | 13G/APassive | 7.7% | 4.80M | Aug 13, 2026 |
| Artisan Investments GP LLC | 13G/APassive | 7.7% | 4.80M | Aug 13, 2026 |
| Artisan Partners Limited Partnership | 13G/APassive | 7.7% | 4.80M | Aug 13, 2026 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13G/APassive | 3.5% | 2.17M | Aug 11, 2026 |
| FMR LLC | 13GPassive | 7.6% | 4.70M | Aug 6, 2026 |